MetaCap

Bruker (BRKR) vs Nautilus Biotechnology (NAUT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bruker (BRKR) has outperformed Nautilus Biotechnology (NAUT) over the past year, gaining 19.4% versus a loss of 5.4%. Over five years, BRKR leads with a -32.2% price change compared with -56.4% for NAUT. Bruker is the larger company by market cap ($8.62 billion vs $270.0 million), about 31.9 times the size.

Bruker pays a dividend yielding 0.09%, while Nautilus Biotechnology does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BRKR+19.44%NAUT-5.36%
+83%+7%-69%
Nov 21, 20251 yearNov 20, 2026
BRKR-32.64%NAUT-57.68%
+26%-33%-92%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BRKR versus NAUT key metrics
MetricBRKRNAUT
Share price$56.46$2.12
Market cap$8.62B$270.03M
1-day change-9.08%-2.30%
YTD return+19.85%+8.72%
1-year return+19.44%-5.36%
5-year return-32.16%-56.38%
Forward P/E23.25—
EPS (TTM)$-1.10$-0.46
Dividend yield0.09%0.00%
Annual dividend$0.05$0.00
Revenue (latest FY)$3.44B—
Revenue growth (YoY)+2.08%—
Net income (latest FY)$-8.60M$-59.00M
Gross margin45.91%—
Operating margin1.98%—
Net margin-0.25%—
52-week high$68.98$4.31
52-week low$32.37$0.841
Distance from 52-week high-18.15%-50.81%
Analyst consensusbuynone
Avg. price target upside+20.44%+88.68%
Average volume2.32M6.25M
Shares outstanding152.72M127.37M
Employees11,085128
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Bruker is about 31.9 times larger than Nautilus Biotechnology by market value ($8.62B vs $270.03M).
  • BRKR has outperformed NAUT by 24.8 percentage points over the past year.

About Bruker

BRKR stock →

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Industrials · Biotechnology: Laboratory Analytical Instruments · 11,085 employees

About Nautilus Biotechnology

NAUT stock →

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.

Industrials · Biotechnology: Laboratory Analytical Instruments · 128 employees

BRKR vs NAUT FAQ

Which is bigger, Bruker or Nautilus Biotechnology?

Bruker (BRKR) is larger, with a market capitalization of $8.62B compared with $270.03M for Nautilus Biotechnology (NAUT).

Which stock has performed better over the past year, BRKR or NAUT?

BRKR returned +19.44% over the past 12 months, compared with -5.36% for NAUT (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Bruker or Nautilus Biotechnology?

Bruker pays a dividend yielding 0.09%, while Nautilus Biotechnology does not currently pay a regular dividend.

Are Bruker and Nautilus Biotechnology in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons